Results 191 to 200 of about 59,165 (246)

No Cystometrogram Among Veterans With Spinal Cord Injury Results in Adverse Urinary System Outcomes

Neurourology and Urodynamics, EarlyView.
ABSTRACT Background A prior study of a large cohort of veterans with supra‐sacral spinal cord injury or disorder (SCI/D) showed, as seen in other cohorts, substantial variation in application of bladder care processes and, specifically in the proportion of patients undergoing cystometrography (CMG). The next step in a systematic evaluation such as this
John Lavelle, John Hornberger
wiley   +1 more source

Long-term survival outcomes following fenestrated endovascular aortic repair: applying population-based life expectancies to contextualize postoperative survival. [PDF]

BJS Open
Leinweber ME, Walter C, Taher F, Assadian A, Hofmann AG.   +4 more
europepmc   +1 more source

On Order Restricted Inference in Multi‐Step Stage Life Testing for a General Family of Distributions

Naval Research Logistics (NRL), EarlyView.
ABSTRACT Recently, k$$ k $$‐step stage life testing (SLT) has been proposed by Laumen and Cramer (2021) as a natural extension of progressive censoring with fixed censoring times (PC‐FCT) as well as of simple step‐stress accelerated life testing (SSALT).
Erhard Cramer, Ayan Pal, Debashis Samanta   +2 more
wiley   +1 more source

Improving accuracy in genome-wide association studies: a two-step approach for handling below limit of detection biomarker measurements. [PDF]

NAR Genom Bioinform
Deng YA, Karlsson T, Johansson Å.
europepmc   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

Obesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu, Hao Dai, Huilin Tang, William T. Donahoo, Thomas J. George, Ramon C. Sun, Sizun Jiang, Aik Choon Tan, Yi Guo, Jonathan D. Licht, John M. Allen, Kelvin P. Lee, Jingchuan Guo, Jiang Bian   +13 more
wiley   +1 more source

Bayesian generalized method of moments applied to pseudo-observations in survival analysis. [PDF]

Lifetime Data Anal
Orsini L, Brard C, Lesaffre E, Yin G, Dejardin D, Le Teuff G.   +5 more
europepmc   +1 more source

Nonparametric Estimation of Transition Intensities in Interval-Censored Markov Multistate Models Without Loops. [PDF]

Stat Med
Gomon D, Putter H.
europepmc   +1 more source

A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 495-509, March 2025.
Abstract Patients with recurrent high‐grade glioma (rHGG) have a poor prognosis with median progression‐free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow‐up imaging studies to adaptively predict the risk of progression.
Daniel J. Glazar, Solmaz Sahebjam, Hsiang‐Husan M. Yu, Dung‐Tsa Chen, Menal Bhandari, Heiko Enderling   +5 more
wiley   +1 more source

Augmented two-stage estimation for treatment switching in oncology trials: Leveraging external data for improved precision. [PDF]

Stat Methods Med Res
Campbell H, Latimer N, Jansen JP, Cope S.   +3 more
europepmc   +1 more source